あなたはここにいる：ホーム > 提携モデル
Both parties will form the alliance based on risk and benefit sharing principle. This will make full use of both parties’ strengths in terms of technology, personnel and facilities to achieve win-win situation.
The main collaboration details are including but not limited to the following:
Please feel free to contact us for more information. Read
With the management capabilities of foreign pharmaceutical enterprises, we could introduce some new drugs from these foreign pharmaceutical enterprises to domestic pharmaceutical companies and fulfill the standards of both China and USA regulations. This would be the new idea for new drug development in China.